News
We came across a bullish thesis on Verve Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this ...
Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild. Crispr Therapeutics rallied for a second day on ...
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest ...
Cathie Wood's ARKK hits a 52-week high after bold biotech moves, signaling renewed momentum in disruptive tech.
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Explore more
The largest transaction of the day was ARK’s acquisition of 102,806 shares of CRISPR Therapeutics AG (NASDAQ: CRSP ), valued at approximately $5.26 million. This purchase through the ARKK ETF reflects ...
Amazon and MercadoLibre lead in retail growth, with AWS, Prime Day, and LATAM dominance driving long-term potential. See why ...
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best CRISPR stocks to buy. Following CRISPR Therapeutics AG (NASDAQ:CRSP ...
The secret to retiring a multi-millionaire is quite simple. There is no easier way to accomplish this than by using a ...
If you were to invest $1,000 in the Vanguard Value Index Fund ETF (NYSEMKT: VTV), how much would you have after five years?
Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results